Brief: Trevi Therapeutics Announces Oral Presentation On Data From Ph2a Canal Trial
04/09/2024 21:13
Sept 4 (Reuters) - Trevi Therapeutics Inc TRVI.O :
* TREVI THERAPEUTICS ANNOUNCES ORAL PRESENTATION ON DATA
FROM PH2A
CANAL TRIAL AT THE EUROPEAN RESPIRATORY SOCIETY CONGRESS 2024
Source text for Eikon: ID:nPn1ssxvma
Further company coverage: TRVI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trevi Therapeutics
See all newsTrevi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Trevi Therapeutics Q2 net loss widens on higher R&D costs
Brief: Trevi Therapeutics Q2 Net Income USD -17.797 Million
Trevi Therapeutics Q1 net loss widens as R&D costs rise
Brief: Trevi Therapeutics Q1 Net Income USD -13.192 Million